Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats

Journal of Neural Transmission

Volumn 116, Issue 7, 2009, Pages 807-814

  Thaakur, Santhrani ^a   Himabindhu, G ^a  

^a INSTITUTE OF PHARMACEUTICAL TECHNOLOGY   (India)

Author keywords

Alpha lipoic acid; Antioxidants; Lipid peroxidation; MDA; Tardive dyskinesia; TAS; VCMs

Indexed keywords

CARBOXYMETHYLCELLULOSE; DIHYDROLIPOATE; HALOPERIDOL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CATALEPSY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FEEDING; LIPID PEROXIDATION; METABOLITE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TARDIVE DYSKINESIA;

ANIMALS; ANTIOXIDANTS; ANTIPSYCHOTIC AGENTS; BRAIN; CATALEPSY; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; FREE RADICALS; HALOPERIDOL; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; THIOCTIC ACID; TREATMENT OUTCOME;

EID: 67651171225     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-009-0232-y     Document Type: Article

References (100)

1. LA Adler E Paselow J Rotrosen E Duncan M Lee M Rosenthal B Angrist 1993 Vitamin E treatment of tardive dyskinesia Am J Psychiatry 150 1405 1407
2. LA Adler E Paselow J Rotrosen E Duncan M Rosenthal B Angrist 1993 Vitamin E in tardive dyskinesia: time course of effect placebo substitution Psychopharmacol Bull 29 371 374
3. LA Adler R Edson P Lavori E Peselow E Duncan M Rosenthal J Rotrosen 1998 Long term effects of vitamin E for tardive dyskinesia Biol Psychiatry 43 868 872 (Pubitemid 28288364)
4. American Psychiatric Association (APA) (1992) Tardive dyskinesia: a task force report of the American Psychiatric Association. APA Press, Washington DC
5. OA Andreassen HA Jorgensen 1995 The rat model of tardive dyskinesia: relationship between vacuous chewing movements and gross motor activity during acute and long term haloperidol treatment Life Sci 57 2263 2272
6. OA Andreassen TO Aam HA Jorgensen 1996 Inhibition by memantine of the development of persistent oral dyskinesias induced by long term haloperidol treatment of rats Br J Pharmacol 119 751 757
7. P Arivazhagan D Ayusawa C Panneerselvam 2006 Protective efficacy of alpha lipoic acid on acetyl choline esterase activity in aged rat brain regions Rejuvenation Res 9 2 198 201
8. Y Barak M Swartz E Shamir D Stein A Weizman 1998 Vitamin E in the treatment of tardive dyskinesia: a statistical meta-analysis Ann Clin Psychiatry 10 101 105
9. C Behl R Rupprecht T Skutella F Holsboer 1995 Haloperidol-induced cell death-mechanism and protection with vitamin E in vitro Neuroreport 7 360 364
10. GP Biewenga GR Haenen A Bast 1997 The pharmacology of the antioxidant lipoic acid Gen Pharmacol 29 3 315 331
11. MS Blios 1958 Antioxidant determination by the use of stable free radical Nature 26 1199
12. PC Burcham 1998 Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous and role in formation of endogenous DNA adducts Mutagenesis 13 287 305
13. Cadenas E, Packer L (1996) Handbook of antioxidants. Marcel Dekker, New York, pp 545-591
14. JL Cadet LA Kahler 1994 Free radical mechanisms in schizophrenia and tardive dyskinesia Neurosci Biobehav Rev 18 457 467
15. JL Cadet JB Lohr 1989 Possible involvement of free radicals in neuroleptic-induced movement disorders Ann N Y Acad Sci 570 176 185
16. JL Cadet JB Lohr DV Jeste 1986 Free radicals and tardive dyskinesia Trends Neurosci 9 107 108
17. DE Casey 1985 Spontaneous and tardive dyskinesias: clinical and laboratory studies J Clin Psychiatry 46 42 47
18. DE Casey 1985 Tardive dyskinesia: reversible and irreversible Psychopharmacology 2 88 97
19. EH Chartoff RP Ward DM Dorsa 1999 Role of adenosine and NMDA receptors in mediating haloperidol-induced gene expression and catalepsy J Pharmacol Exp Ther 291 2 591 597
20. YC Chen SC Shen WR Lee WC Hou LL Yang TJ Lee 2001 Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expression by rutin, quercetin and quercetin penta acetate in RAW 264.7 macrophages J Cell Biochem 82 537 548
21. A Clow P Jenner CD Marsden 1979 Changes in dopamine mediated behaviour during one year's neuroleptic administration Eur J Pharmacol 57 365 375
22. G Cohen MB Spina 1989 Deprenyl suppresses the oxidant stress associated with increased dopamine turnover Ann Neurol 26 689 690
23. I Creese DR Burt SH Snyder 1976 Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs Science 192 481 483
24. MT Egan TM Hyde GW Albers A Elkashef RC Alexander A Reeve A Blum RE Saez RJ Wyatt 1992 Treatment of tardive dyskinesia with vitamin E Am J Psychiatry 149 773 777
25. MF Egan TM Hyde JE Kleinman RJ Wyatt 1995 Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long term increases in haloperidol dose Psychopharmacology 117 74 81
26. AM Elkashef RJ Wyatt 1999 Tardive dyskinesia: possible involvement of free radical and treatment with vitamin E Schizophr Bull 25 731 740
27. AM Elkashef PE Ruskin N Bacher D Barett 1990 Vitamin E in the treatment of tardive dyskinesia Am J Psychiatry 147 505 506
28. Esterbaur H, Zollner H, Schaur RJ (1990) Aldehydes formed by lipid peroxidation mechanism of formation, occurrence and determination. In: Vigopelfrey C (ed) Membrane lipid peroxidation. CRC, Baco Raton
29. H Esterbauer RJ Schaur H Zollner 1991 Chemistry and biochemistry of 4-hydroxy alkenal, malondialdehyde and related aldehydes Free Radic Biol Med 11 81 128
30. RR Faria VC Abilio C Grassl CC Chinen LTR Negrao JPMV Castro DF Fukshiro MSD Rodrigues PHZ Gomes S Registro RCC Carvalho V D'Almeida RH Silva RA Ribeiro R Fussa-Filho 2005 Beneficial effects of vitamin C and vitamin E on reserpine induced oral dyskinesia in rats: critical role of strital catalase activity Neuropharmacology 48 993 1001
31. Freeman BA, Capro JD (1982) Biology of disease: free radicals and tissue injury. Lab Invest 47:412-425; Chem 243:5753-5756
32. WM Glazer H Morgenstern N Schooler CS Berkman DC Moore 1990 Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication Br J Psychiatry 157 585 592
33. Goyal RK, Patel NM, Bhatt RV, Mehta AA, Prabhakhar MC (2006) Study of catalepsy in animals. In: Practicals in pharmacology, 5th edn. B S Shah Prakashan, Ahmedabad, pp 128
34. LM Gunne J Growdon B Glaeser 1982 Oral dyskinesia in rats following brain lesions and neuroleptic drug administration Psychopharmacology 77 134 139
35. Gunne LM, Andersson U, Bondesson U, Johansson (1986) Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration. Pharmacol Biochem Behav 25:897-901
36. S Gupta D Monsik DW Black S Berry PS Masand 1999 Tardive dyskinesia; review of treatments past, present, and future Ann Clin Psychiatry 11 257 266
37. B Halliwell JMC Gutteridge EC Carrol 1994 Free radicals, antioxidants and human disease: where are we now? J Lab Clin Med 119 598 619
38. TM Hyde MF Egan LL Wing RJ Wyatt DR Weinberger JE Kleinman 1995 Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate Psychopharmacology (Berl) 118 142 149
39. SD Iversen RB Howells RP Hughes 1980 Behavioral consequences of long-term treatment with neuroleptic drugs Adv Biochem Psychopharmacol 24 305 313
40. DV Jeste SG Potkin S Sinha S Feder RJ Wyatt 1979 Tardive dyskinesia-reversible and persistent Arch Gen Psychiatry 36 585 590
41. JM Kane JM Smith 1982 Tardive dyskinesia: prevalence and risk factors, 1959 to 1979 Arch Gen Psychiatry 39 473 481
42. H Kaneda O Shirakawa J Dale L Goodman SE Bachus CA Tamminga 1992 Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats Eur J Pharmacol 212 43 49
43. JN Keller MP Mattson 1998 Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction and death in the nervous system Rev Neurosci 9 105 116
44. Kramer K, Packer L (2001) R-alpha lipoic acid. In: Kramer K, Hoppe P, Packer L (eds) Neutraceuticals in health and disease prevention. Marcel Dekker, New York
45. MH Lee RD Lin LY Shen YY Yang KY Yen WC Hou 2001 Monoamino oxidase B and free radical scavenging activities of natural flavonoids in melastoma candidum D Don J Argic Food Chem 49 5551 5555
46. JB Lohr JL cadet MA Lohr DV Jeste RJ Wyatt 1987 Alpha-tocopherol in tardive dyskinesia Lancet 1 913 914
47. JB Lohr R Kuczenski HS Bracha M Moir DV Joste 1990 Increased indices of free radical activity in cerebrospinal fluid of patients with tardive dyskinesia Biol Psychiatry 28 533 539
48. BA Maddux W See JC Lawrence AL Goldfine ID Goldfine JL Evans 2001 Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micro molar concentrations of alpha-lipoic acid Diabetes 50 404 410
49. SP Mahadik S Gowda 1996 Antioxidants in the treatment of schizophrenia Drugs Today 32 553 565
50. SP Mahadik RE Scheffer 1996 Oxidative injury and potential use of antioxidants of schizophrenia Prostaglandins Leukot Essent Fatty Acids 55 45 54
51. Mahadik SP, Sitasawad V, Mulchandani M (1999) Membrane peroxidation and the neuropathology of schizophrenia. In: Peet M, Glen I, Horrobin DF (eds) Phospholipids spectrum disorders in psychiatry. Marius Press, Lancashire
52. SP Mahadik D Evans H Lal 2001 Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 25 463 493
53. AC Maritim RA Sanders JB Watkins III 2003 The effect of α-lipoic acid on biomarkers of oxidative stress in streptozocin induced diabetic rats J Nutr Biochem 14 88 294
54. AD Muthuswamy K Vedagiri M Ganesan P Chinnakannu 2006 Oxidative stress mediated molecular damage and dwindle in antioxidant status in aged rat brain regions: role of l-carnitine and dl-alpha lipoic acid Clin Chim Acta 368 84 92
55. PS Naidu SK Kulkarni 2001 Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide Behav Pharmacol 12 3 209 216
56. PS Naidu SK Kulkarni 2001 Possible involvement of prostaglandins in haloperidol-induced orofacial dyskinesia in rats Eur J Pharmacol 430 295 298
57. PS Naidu SK Kulkarni 2004 Quercetin, a bioflavonoid, reverses haloperidol-induced catalepsy Methods Find Exp Clin Pharmacol 26 323 326
58. PS Naidu A Singh P Kaur R Sandhir SK Kulkarni 2003 Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia Pharmacol Biochem Behav 74 641 648 (Pubitemid 36126542)
59. PS Naidu A Singh SK Kulkarni 2003 Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia Neuropharmacology 44 1100 1106 (Pubitemid 36570433)
60. WG Nichans D Samuelson 1968 Formation of malondialdehyde from phospholipids arachidonate during microsomal lipid peroxidation Eur J Biochem 6 126 130
61. EB Nielson M Lyon 1978 Evidence for cell loss in corpus striatum after long term treatment with a neuroleptic drug (flupenthixol) in rats Psychopharmacology 59 85 89
62. IG Obrosova L Fathallah L Edwin J Nourooz-Zadeh 2003 Early changes oxidative stress in the diabetic kidney: effect of dl-α-lipoic acid Free Radic Boil Med 34 20 186 195
63. IG Obrosova L Fathallah DA Greene 2003 Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of dl-α-lipoic acid Eur J Pharmacol 398 139 146
64. L Packer KH Witt HJ Tristschler 1995 Alpha-lipoic acid as a biological antioxidant Free Radic Biol Med 19 227 250
65. L Packer K Kraemer G Rimbach 2001 Molecular aspects of lipoic acid in the prevention of diabetes complications Nutrition 17 888 895
66. HS Pall AC Williams DR Blake J Lunec 1987 Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines Lancet 2 596 599
67. V Parikh M Mohammad Khan P Sahebarao Mahadik 2003 Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain J Psychiatr Res 37 43 51
68. M Pascand 1993 The essential polyunsaturated fatty acids of spirulina and our immune response Bull Inst Oceanogr 12 49 57
69. M Peet J Langharne N Rangarajan GP Renolds 1993 Tardive dyskinesia, lipid peroxidation and sustained amelioration with vitamin E treatment Int Clin Psychopharmacol 8 151 153
70. JG Pires V Bonikovski HA Furturo-Neto 2005 Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice Braz J Med Biol Res 38 1867 1872
71. A Post F Holsboer C Behl 1998 Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants J Neurosci 18 8236 8246
72. GM Raso R Meli R Di Carlo 2001 Inhibition of inducible nitric oxide synthase and cyclooxygenase expression by flavonoids in macrophage J773A.I Life Sci 12 921 931
73. V Ravindranath DJ Reed 1990 Glutathione depletion and formation of glutathione protein mixed disulfide following exposure of brain mitochondria to oxidative stress Biochem Biophys Res Commun 169 150 158
74. R Reddy JK Yao 1996 Free radical pathology in schizophrenia: a review Prostaglandins Leukot Essent Fatty Acids 55 33 43
75. S Roy L Packer 1998 Redox regulation of cell function by alpha-lipoate: biochemical and molecular aspects Biofactors 7 263 267 (Pubitemid 28149726)
76. Y Sagara 1998 Induction of reactive oxygen species in neurons by haloperidol J Neurochem 71 1002 1012
77. M Sahin G Sagdic O Elmas D Akpinar N Derin M Asian A Agar Y Aliciguzel P Yargicoglu 2006 Effect of chronic resistant stress and alpha lipoic acid on lipid peroxidation and antioxidant enzyme activity in rat peripheral organs Pharmacol Res 54 3 247 252
78. PR Sanberg MD Bunsey M Giordano 1988 The catalepsy test: its ups and downs Behav Neurosci 102 748 759
79. H Sasaki K Hashimoto Y Maeda T Inada Y Kitao S Fukui M Iyo 1995 Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats Life Sci 56 443 447
80. P Scapicchio P Decina S Mukherjee G Caracci 1991 Effects of α-tocopherol on persistent tardive dyskinesia in elderly schizophrenic patients Ital J Psychiatry Behav Sci 1 111 114
81. H Scholich ME Murphy H Sies 1989 Antioxidant activity of dihydrolipoate against microsomal lipid peroxidation and its dependence on alpha-tocopherol Biochem Biophys Acta 1001 256 261 (Pubitemid 19051280)
82. RE See 1991 Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride Neurosci Lett 129 265 268
83. S Sethumadhavan P Chinnakannu 2006 l-Carnitine and alpha lipoic acid improve age associated decline in mitochondrial respiratory activity of rat heart muscle J Gerontol A Biol Sci Med Sci 61 7 650 659
84. Sies H (1985) Oxidative stress: introductory remarks. In: Sies H (ed) Oxidative stress. Academic, London, pp 1-5
85. E Shamir Y Barak I Plopsky N Zisapel A Elizur A Weizman 2000 Is melatonin treatment effective for tardive dyskinesia? J Clin Psychiatry 61 556 558
86. E Shamir Y Barak I Shalman M Laudon N Zisapel 2001 Melatonin treatment for tardive dyskinesia Arch Gen Psychiatry 58 1049 1052
87. Sharma S, Paladino P, Gabriele J, Saeedi H, Henry P, Chang M, Mishra RK, Johnson RL (2003) Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: a model of human tardive dyskinesia. Peptides 2:313-319
88. 1 binding site correlates of haloperidol-induced oral dyskinesias in rat Exp Neurol 127 62 69
89. BR Shivakumar V Ravindranath 1993 Oxidative stress and thiol modification induced by chronic administration of haloperidol J Pharmacol Exp Ther 265 1137 1141
90. KJ Skoblenick JM Castellano RM Rogoza BA Dyck N Thomas JP Gabriele VZ Chong RK Mishra 2006 Translocation of AIF in the human and rat striatum following protracted haloperidol, but not clozapine treatment Apoptosis 11 5 663 672
91. KV Soares JJ McGrath 2000 Vitamin E for neuroleptic-induced tardive dyskinesia Cochrane Database Syst Rev 2 CD000209
92. B Subramaniam H Rollema T Woolf NG Castagnoli 1990 Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats Biochem Biophys Res Commun 166 238 244
93. K Sugioka Y Shimosegawa M Nakano 1987 Estrogens as natural antioxidants of membrane phospholipids peroxidation FEBS Lett 210 37 39
94. Thaakur SR, Jyothi B (2007) Effect of spirulina maxima on the tardive dyskinesia and oxidative stress induced by haloperidol in rats. J Neural Transm. doi: 10.1007/S00702-007-0744
95. W Ukai H Ozawa M Tateno E Hashimoto T Saito 2004 Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol J Neural Transm 111 667 681
96. A Verma SK Kulkarni 1992 D1/D2 dopamine and NMDA receptor participation in experimental catalepsy in rats Psychopharmacology 109 4 477 483
97. PF Von Voigtlander MA Burian JS Althaus LR Willams 1990 Effects of chronic haloperidol on vitamin E levels and monoamine metabolism in rats fed normal and vitamin E deficient diets Res Commun Chem Pathol Pharmacol 68 3 343 352
98. JL Waddington 1990 Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration. Phenomenology, pathophysiology and putative relationship to tardive dyskinesia Psychopharmacology 101 431 447
99. JK Yao R Reddy LG Elhinny DP Vankammen 1998 Effects of haloperidol on antioxidant defense system enzymes in schizophrenia J Psychiatr Res 32 385 391
100. WJ Zhang B Frei 2001 Alpha lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells FASEB J 15 13 2423 2432